Olema Pharmaceuticals (OLMA) Other Non-Current Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) has reported Other Non-Current Assets for 7 consecutive years, with $16.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 38.37% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $16.5 million (up 38.37% YoY), while the FY2025 annual figure was $16.8 million, up 112113.33% from the prior year.
• Other Non-Current Assets declined to $16.5 million in Q1 2026 per OLMA's latest filing, from $16.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $16.8 million in Q4 2025 and bottomed at $15000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $8.2 million across 5 years, with a median of $8.1 million in 2023.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets sank 99.82% — and 2025, when it jumped 112113.33%.
• Olema Pharmaceuticals' Other Non-Current Assets stood at $4.3 million in 2022, then soared by 91.51% to $8.1 million in 2023, then tumbled by 99.82% to $15000.0 in 2024, then surged by 112113.33% to $16.8 million in 2025, then declined by 2.0% to $16.5 million in 2026.
• Business Quant data shows OLMA's Other Non-Current Assets at $16.5 million in Q1 2026, $16.8 million in Q4 2025, and $16.7 million in Q3 2025.